Chen, Y., Dong, X., Wang, Q., Liu, Z., Dong, X., Shi, S., & Xiao, H. (2020). Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia. Front Pharmacol.
Chicago-tyylinen lähdeviittausChen, Yan, Xiuhua Dong, QiuJu Wang, ZhiXi Liu, XinWei Dong, Sanjun Shi, ja HongTao Xiao. "Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia." Front Pharmacol 2020.
MLA-viiteChen, Yan, et al. "Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia." Front Pharmacol 2020.